Search Menu
Photonics Media Photonics Marketplace Photonics Spectra BioPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook

Caliber Imaging & Diagnostics Names New CFO

Facebook Twitter LinkedIn Email
BOSTON and ROCHESTER, N.Y., March 31, 2014 — Caliber Imaging & Diagnostics, formerly Lucid Inc., has named Richard C. Christopher as chief financial officer. He replaces Richard J. Pulsifer. Christopher served for eight years as CFO of DUSA Pharmaceuticals Inc., overseeing its sale to Sun Pharmaceuticals Industries Limited for $230 million in 2012.

Caliber is the developer of VivaScope, is a disruptive, noninvasive point-of-care platform imaging technology with applications in cosmetics, dermatology, surgery and research. The technology enables physicians to detect cancerous lesions that appear benign, reducing the need for biopsies. The company says such lesions show no malignancy approximately 70 percent of the time.

Christopher holds a master’s degree in accounting from Suffolk University in Boston and a bachelor’s degree in finance from Bentley College in Waltham, Mass.

DUSA Pharmaceuticals, Christopher’s previous employer, developed the Levulan Photodynamic Therapy technology platform for the treatment of precancerous skin lesions.

"During my tenure at DUSA Pharmaceuticals, I came to appreciate the specific challenges facing a small publicly traded company developing new technology for the skin cancer market,” Christopher said. “In my new role at Caliber I.D., I intend to work closely with the rest of the management team and apply my insights in an effort to position the company for future growth. I believe the strong value proposition of the VivaScope devices offers a firm foundation for an increasingly robust bottom line."

"Rich Christopher has the ideal background to oversee Caliber I.D.'s future financial growth,” said Caliber CEO L. Michael Hone. “Having been involved with a startup company through its growth stages and eventual sale, he has specific expertise ranging from capital markets to strategic planning, that we, as an emerging company, will benefit from. We look forward to capitalizing on his keen judgment in the months and years to come. We would also like to thank Richard Pulsifer for the tremendous job he has done as CFO, and wish him the best of luck in his future endeavors.”

For more information, visit:
Mar 2014
AmericasBiophotonicsBusinesscosmeticsdermatologyDUSA PharmaceuticalsimagingResearch & TechnologySkin Cancer ImagingsurgeryTest & MeasurementCaliber Imaging & DiagnosticsRichard C. ChristopherVivaScopeL. Michael HoneRichard Pulsifer

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2023 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, [email protected]

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.